{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:11:58Z","timestamp":1768561918421,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"DOI":"10.7759\/cureus.89943","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T04:24:57Z","timestamp":1755059097000},"source":"Crossref","is-referenced-by-count":0,"title":["Potential Role of Oral Microbiota in Medication-Related Osteonecrosis of the Jaw in Cancer Patients: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Rawan J","family":"Al Harrasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaisha Y","family":"Al Balushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma I","family":"Al Kindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia A","family":"Al Kindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany H","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202103_25430","article-title":"Treatment of medication-related osteonecrosis of the jaw (MRONJ). A systematic review","volume":"25","author":"Goker F","year":"2021","unstructured":"Goker F, Grecchi E, Grecchi F, Francetti L, Del Fabbro M. Treatment of medication-related osteonecrosis of the jaw (MRONJ). A systematic review. Eur Rev Med Pharmacol Sci. 2021, 25:2662-73. 10.26355\/eurrev_202103_25430","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.866871","article-title":"Oral complications in cancer patients-medication-related osteonecrosis of the jaw (MRONJ)","volume":"3","author":"Migliorati CA","year":"2022","unstructured":"Migliorati CA. Oral complications in cancer patients-medication-related osteonecrosis of the jaw (MRONJ). Front Oral Health. 2022, 3:866871. 10.3389\/froh.2022.866871","journal-title":"Front Oral Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s13187-025-02639-6","article-title":"The role of dental oncology in cancer care: a critical component of comprehensive treatment, education, and interdisciplinary collaboration- a narrative review","author":"Kamel AH","year":"2025","unstructured":"Kamel AH, AlKindi F, AlHarrasi R, AlKindi N. The role of dental oncology in cancer care: a critical component of comprehensive treatment, education, and interdisciplinary collaboration- a narrative review. J Cancer Educ. 2025, 10.1007\/s13187-025-02639-6","journal-title":"J Cancer Educ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-024-03945-z","article-title":"Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study","volume":"24","author":"Kim HY","year":"2024","unstructured":"Kim HY, Jung YS, Park W, Choi YJ, Kim JY. Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study. BMC Oral Health. 2024, 24:160. 10.1186\/s12903-024-03945-z","journal-title":"BMC Oral Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00873-0","article-title":"Microbiome in radiotherapy: an emerging approach to enhance treatment efficacy and reduce tissue injury","volume":"30","author":"Lu L","year":"2024","unstructured":"Lu L, Li F, Gao Y, Kang S, Li J, Guo J. Microbiome in radiotherapy: an emerging approach to enhance treatment efficacy and reduce tissue injury. Mol Med. 2024, 30:105. 10.1186\/s10020-024-00873-0","journal-title":"Mol Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00542-10","article-title":"The human oral microbiome","volume":"192","author":"Dewhirst FE","year":"2010","unstructured":"Dewhirst FE, Chen T, Izard J, et al.. The human oral microbiome. J Bacteriol. 2010, 192:5002-17. 10.1128\/JB.00542-10","journal-title":"J Bacteriol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.895537","article-title":"The oral microbiota: community composition, influencing factors, pathogenesis, and interventions","volume":"13","author":"Li X","year":"2022","unstructured":"Li X, Liu Y, Yang X, Li C, Song Z. The oral microbiota: community composition, influencing factors, pathogenesis, and interventions. Front Microbiol. 2022, 13:895537. 10.3389\/fmicb.2022.895537","journal-title":"Front Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036217","article-title":"Spatiotemporally controlled cardiac conduction block using high-frequency electrical stimulation","volume":"7","author":"Dura B","year":"2012","unstructured":"Dura B, Kovacs GT, Giovangrandi L. Spatiotemporally controlled cardiac conduction block using high-frequency electrical stimulation. PLoS One. 2012, 7:36217. 10.1371\/journal.pone.0036217","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.2041-1014.2012.00663.x","article-title":"Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology","volume":"27","author":"Hajishengallis G","year":"2012","unstructured":"Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012, 27:409-19. 10.1111\/j.2041-1014.2012.00663.x","journal-title":"Mol Oral Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12090205","article-title":"Medication-related osteonecrosis of the jaw: a systematic review of case reports and case series","volume":"12","author":"Frutuoso F","year":"2024","unstructured":"Frutuoso F, Freitas F, Vilares M, Francisco H, Marques D, Caram\u00eas J, Moreira A. Medication-related osteonecrosis of the jaw: a systematic review of case reports and case series. Diseases. 2024, 12:205. 10.3390\/diseases12090205","journal-title":"Diseases"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51183","article-title":"A narrative review of osteonecrosis of the jaw: what a clinician should know","volume":"15","author":"Sharma S","year":"2023","unstructured":"Sharma S, Shankar R, Ravi Kiran BS, Breh R, Sarangi S, Kumar Upadhyay A. A narrative review of osteonecrosis of the jaw: what a clinician should know. Cureus. 2023, 15:51183. 10.7759\/cureus.51183","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097948","article-title":"Immune dysfunction in medication-related osteonecrosis of the jaw","volume":"24","author":"Roato I","year":"2023","unstructured":"Roato I, Mauceri R, Notaro V, Genova T, Fusco V, Mussano F. Immune dysfunction in medication-related osteonecrosis of the jaw. Int J Mol Sci. 2023, 24:7948. 10.3390\/ijms24097948","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0022034520908594","article-title":"Indigenous microbiota protects against inflammation-induced osteonecrosis","volume":"99","author":"Williams DW","year":"2020","unstructured":"Williams DW, Vuong HE, Kim S, et al.. Indigenous microbiota protects against inflammation-induced osteonecrosis. J Dent Res. 2020, 99:676-84. 10.1177\/0022034520908594","journal-title":"J Dent Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10785","article-title":"Pathophysiology of medication-related osteonecrosis of the jaw-a minireview","volume":"7","author":"Tetradis S","year":"2023","unstructured":"Tetradis S, Allen MR, Ruggiero SL. Pathophysiology of medication-related osteonecrosis of the jaw-a minireview. JBMR Plus. 2023, 7:10785. 10.1002\/jbm4.10785","journal-title":"JBMR Plus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2174\/1874325000903010083","article-title":"Alendronate inhibits VEGF expression in growth plate chondrocytes by acting on the mevalonate pathway","volume":"3","author":"Evans KD","year":"2009","unstructured":"Evans KD, Oberbauer AM. Alendronate inhibits VEGF expression in growth plate chondrocytes by acting on the mevalonate pathway. Open Orthop J. 2009, 3:83-8. 10.2174\/1874325000903010083","journal-title":"Open Orthop J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.606043","article-title":"The role of the immune response in the development of medication-related osteonecrosis of the jaw","volume":"12","author":"Zhang W","year":"2021","unstructured":"Zhang W, Gao L, Ren W, et al.. The role of the immune response in the development of medication-related osteonecrosis of the jaw. Front Immunol. 2021, 12:606043. 10.3389\/fimmu.2021.606043","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194367","article-title":"Medication-related osteonecrosis of the jaw: a critical narrative review","volume":"10","author":"Lorenzo-Pouso AI","year":"2021","unstructured":"Lorenzo-Pouso AI, Bag\u00e1n J, Bag\u00e1n L, et al.. Medication-related osteonecrosis of the jaw: a critical narrative review. J Clin Med. 2021, 10:4367. 10.3390\/jcm10194367","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158053","article-title":"Bisphosphonate-related osteonecrosis of the jaw and oral microbiome: clinical risk factors, pathophysiology and treatment options","volume":"25","author":"Jelin-Uhlig S","year":"2024","unstructured":"Jelin-Uhlig S, Weigel M, Ott B, Imirzalioglu C, Howaldt HP, B\u00f6ttger S, Hain T. Bisphosphonate-related osteonecrosis of the jaw and oral microbiome: clinical risk factors, pathophysiology and treatment options. Int J Mol Sci. 2024, 25:8053. 10.3390\/ijms25158053","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1254516","article-title":"Oral microbiota-host interaction: the chief culprit of alveolar bone resorption","volume":"15","author":"Xu J","year":"2024","unstructured":"Xu J, Yu L, Ye S, Ye Z, Yang L, Xu X. Oral microbiota-host interaction: the chief culprit of alveolar bone resorption. Front Immunol. 2024, 15:1254516. 10.3389\/fimmu.2024.1254516","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2016.11.011","article-title":"Bacterial diversity in medication-related osteonecrosis of the jaw","volume":"123","author":"Hallmer F","year":"2017","unstructured":"Hallmer F, Bj\u00f8rnland T, Andersson G, Becktor JP, Kristoffersen AK, Enersen M. Bacterial diversity in medication-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017, 123:436-44. 10.1016\/j.oooo.2016.11.011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.751503","article-title":"Oral osteomicrobiology: the role of oral microbiota in alveolar bone homeostasis","volume":"11","author":"Cheng X","year":"2021","unstructured":"Cheng X, Zhou X, Liu C, Xu X. Oral osteomicrobiology: the role of oral microbiota in alveolar bone homeostasis. Front Cell Infect Microbiol. 2021, 11:751503. 10.3389\/fcimb.2021.751503","journal-title":"Front Cell Infect Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2013.1406","article-title":"Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells","volume":"32","author":"Hou GQ","year":"2013","unstructured":"Hou GQ, Guo C, Song GH, et al.. Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells. Int J Mol Med. 2013, 32:503-10. 10.3892\/ijmm.2013.1406","journal-title":"Int J Mol Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2018.02.008","article-title":"The impact of chemotherapeutic treatment on the oral microbiota of patients with cancer: a systematic review","volume":"125","author":"Villafuerte KR","year":"2018","unstructured":"Villafuerte KR, Martinez CJ, Dantas FT, Carrara HH, Dos Reis FJ, Palioto DB. The impact of chemotherapeutic treatment on the oral microbiota of patients with cancer: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018, 125:552-66. 10.1016\/j.oooo.2018.02.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3402\/jom.v2i0.5195","article-title":"Oral microbiota and cancer","volume":"2","author":"Meurman JH","year":"2010","unstructured":"Meurman JH. Oral microbiota and cancer. J Oral Microbiol. 2010, 2:10.3402\/jom.v2i0.5195","journal-title":"J Oral Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10122413","article-title":"Oral microorganisms and biofilms: new insights to defeat the main etiologic factor of oral diseases","volume":"10","author":"Bertolini M","year":"2022","unstructured":"Bertolini M, Costa RC, Bar\u00e3o VA, Cunha Villar C, Retamal-Valdes B, Feres M, Silva Souza JG. Oral microorganisms and biofilms: new insights to defeat the main etiologic factor of oral diseases. Microorganisms. 2022, 10:2413. 10.3390\/microorganisms10122413","journal-title":"Microorganisms"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10204762","article-title":"Cancer patients at risk for medication-related osteonecrosis of the jaw. A case and control study analyzing predictors of MRONJ onset","volume":"10","author":"Marcian\u00f2 A","year":"2021","unstructured":"Marcian\u00f2 A, Ingrasciotta Y, Isgr\u00f2 V, et al.. Cancer patients at risk for medication-related osteonecrosis of the jaw. A case and control study analyzing predictors of MRONJ onset. J Clin Med. 2021, 10:4762. 10.3390\/jcm10204762","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.970074","article-title":"Oral infections in oral cancer survivors: a mini-review","volume":"3","author":"Pispero A","year":"2022","unstructured":"Pispero A, Lombardi N, Manfredi M, Varoni EM, Sardella A, Lodi G. Oral infections in oral cancer survivors: a mini-review. Front Oral Health. 2022, 3:970074. 10.3389\/froh.2022.970074","journal-title":"Front Oral Health"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2012.01916.x","article-title":"Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw","volume":"18","author":"Wei X","year":"2012","unstructured":"Wei X, Pushalkar S, Estilo C, et al.. Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw. Oral Dis. 2012, 18:602-12. 10.1111\/j.1601-0825.2012.01916.x","journal-title":"Oral Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens LM","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002, 420:860-7. 10.1038\/nature01322","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-022-00166-4","article-title":"Indigenous microbiota protects development of medication-related osteonecrosis induced by periapical disease in mice","volume":"14","author":"Du W","year":"2022","unstructured":"Du W, Yang M, Kim T, et al.. Indigenous microbiota protects development of medication-related osteonecrosis induced by periapical disease in mice. Int J Oral Sci. 2022, 14:16. 10.1038\/s41368-022-00166-4","journal-title":"Int J Oral Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0568-z","article-title":"Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw","volume":"13","author":"Kalyan S","year":"2015","unstructured":"Kalyan S, Wang J, Quabius ES, Huck J, Wiltfang J, Baines JF, Kabelitz D. Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw. J Transl Med. 2015, 13:212. 10.1186\/s12967-015-0568-z","journal-title":"J Transl Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14020203","article-title":"The microbiological background of medication-related osteonecrosis of the jaw (MRONJ): clinical evidence based on traditional culture and molecular biological detection methods","volume":"14","author":"K\u00f6v\u00e9r Z","year":"2025","unstructured":"K\u00f6v\u00e9r Z, Gajd\u00e1cs M, Polg\u00e1r B, Szab\u00f3 D, Urb\u00e1n E. The microbiological background of medication-related osteonecrosis of the jaw (MRONJ): clinical evidence based on traditional culture and molecular biological detection methods. Antibiotics (Basel). 2025, 14:203. 10.3390\/antibiotics14020203","journal-title":"Antibiotics (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgz002","article-title":"Oral microbiome and cancer therapy-induced oral mucositis","volume":"2019","author":"Mougeot JC","year":"2019","unstructured":"Mougeot JC, Stevens CB, Morton DS, Brennan MT, Mougeot FB. Oral microbiome and cancer therapy-induced oral mucositis. J Natl Cancer Inst Monogr. 2019, 2019:53. 10.1093\/jncimonographs\/lgz002","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/cid.12297","article-title":"Biomarkers for bisphosphonate-related osteonecrosis of the jaw","volume":"18","author":"Kim JW","year":"2016","unstructured":"Kim JW, Cha IH, Kim SJ, Kim MR. Biomarkers for bisphosphonate-related osteonecrosis of the jaw. Clin Implant Dent Relat Res. 2016, 18:281-91. 10.1111\/cid.12297","journal-title":"Clin Implant Dent Relat Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212405","article-title":"Insights into medication-induced osteonecrosis of the jaw through the application of salivary proteomics and bioinformatics","volume":"25","author":"Schwartzov\u00e1 V","year":"2024","unstructured":"Schwartzov\u00e1 V, Laputkov\u00e1 G, Talian I, Marcin M, Schwartzov\u00e1 Z, Glaba D. Insights into medication-induced osteonecrosis of the jaw through the application of salivary proteomics and bioinformatics. Int J Mol Sci. 2024, 25:12405. 10.3390\/ijms252212405","journal-title":"Int J Mol Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220712","article-title":"Metabolomic profiling reveals salivary hypotaurine as a potential early detection marker for medication-related osteonecrosis of the jaw","volume":"14","author":"Yatsuoka W","year":"2019","unstructured":"Yatsuoka W, Ueno T, Miyano K, et al.. Metabolomic profiling reveals salivary hypotaurine as a potential early detection marker for medication-related osteonecrosis of the jaw. PLoS One. 2019, 14:0220712. 10.1371\/journal.pone.0220712","journal-title":"PLoS One"},{"key":"ref37","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola CL","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015, 40:277-83.","journal-title":"P T"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander JL","year":"2017","unstructured":"Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol. 2017, 14:356-65. 10.1038\/nrgastro.2017.20","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2016.102","article-title":"The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis","volume":"70","author":"Wang YH","year":"2016","unstructured":"Wang YH, Yao N, Wei KK, Jiang L, Hanif S, Wang ZX, Pei CX. The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis. Eur J Clin Nutr. 2016, 70:1246-53. 10.1038\/ejcn.2016.102","journal-title":"Eur J Clin Nutr"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2013.08.018","article-title":"Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy","volume":"21","author":"Mego M","year":"2013","unstructured":"Mego M, Holec V, Drgona L, Hainova K, Ciernikova S, Zajac V. Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy. Complement Ther Med. 2013, 21:712-23. 10.1016\/j.ctim.2013.08.018","journal-title":"Complement Ther Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu106","article-title":"The efficacy and safety of probiotics in people with cancer: a systematic review","volume":"25","author":"Redman MG","year":"2014","unstructured":"Redman MG, Ward EJ, Phillips RS. The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol. 2014, 25:1919-29. 10.1093\/annonc\/mdu106","journal-title":"Ann Oncol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321153","article-title":"The role of gut microbiota in cancer treatment: friend or foe?","volume":"69","author":"Cheng WY","year":"2020","unstructured":"Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe?. Gut. 2020, 69:1867-76. 10.1136\/gutjnl-2020-321153","journal-title":"Gut"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.61872\/sdj-2023-06-01","article-title":"Clinical guidance for maintaining oral hygiene in patients undergoing chemotherapy or radiation therapy: a scoping review","volume":"133","author":"Chan J","year":"2023","unstructured":"Chan J, Filippi F, Filippi C. Clinical guidance for maintaining oral hygiene in patients undergoing chemotherapy or radiation therapy: a scoping review. Swiss Dent J. 2023, 133:368-79. 10.61872\/sdj-2023-06-01","journal-title":"Swiss Dent J"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.876941","article-title":"Dental evaluation prior to cancer therapy","volume":"3","author":"Yong CW","year":"2022","unstructured":"Yong CW, Robinson A, Hong C. Dental evaluation prior to cancer therapy. Front Oral Health. 2022, 3:876941. 10.3389\/froh.2022.876941","journal-title":"Front Oral Health"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/srep31604","article-title":"The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection","volume":"6","author":"Russmueller G","year":"2016","unstructured":"Russmueller G, Seemann R, Weiss K, et al.. The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection. Sci Rep. 2016, 6:31604. 10.1038\/srep31604","journal-title":"Sci Rep"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1556\/1886.2023.00041","article-title":"Role of Actinomyces spp. and related organisms in the development of medication-related osteonecrosis of the jaw (MRONJ): clinical evidence based on a case series","volume":"13","author":"K\u00f6v\u00e9r Z","year":"2023","unstructured":"K\u00f6v\u00e9r Z, B\u00e1n \u00c1, Gajd\u00e1cs M, Polg\u00e1r B, Urb\u00e1n E. Role of Actinomyces spp. and related organisms in the development of medication-related osteonecrosis of the jaw (MRONJ): clinical evidence based on a case series. Eur J Microbiol Immunol (Bp). 2023, 13:125-34. 10.1556\/1886.2023.00041","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-018-2655-z","article-title":"Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw","volume":"23","author":"Zirk M","year":"2019","unstructured":"Zirk M, Wenzel C, Buller J, Z\u00f6ller JE, Zinser M, Peters F. Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw. Clin Oral Investig. 2019, 23:2143-51. 10.1007\/s00784-018-2655-z","journal-title":"Clin Oral Investig"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5466\/ijoms.15.85","article-title":"Importance of professional oral hygiene in preventing medication-related osteonecrosis of the jaw","volume":"15","author":"Ohnishi Y","year":"2017","unstructured":"Ohnishi Y, Ito K, Kitamura R, Funayama S, Hori K, Inoue M. Importance of professional oral hygiene in preventing medication-related osteonecrosis of the jaw. Int J Oral Med Sci. 2017, 15:85-92. 10.5466\/ijoms.15.85","journal-title":"Int J Oral Med Sci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2018.08.003","article-title":"Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: a systematic review with meta-analyses","volume":"85","author":"Karna H","year":"2018","unstructured":"Karna H, Gonzalez J, Radia HS, Sedghizadeh PP, Enciso R. Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: a systematic review with meta-analyses. Oral Oncol. 2018, 85:15-23. 10.1016\/j.oraloncology.2018.08.003","journal-title":"Oral Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.61919\/jhrr.v4i1.624","article-title":"Relationship of oral hygiene and oral mucositis with concurrent chemo-radiotherapy in head and neck cancers","volume":"4","author":"Shafique S","year":"2024","unstructured":"Shafique S, Siddique H, Rahim RG, Haroon HM. Relationship of oral hygiene and oral mucositis with concurrent chemo-radiotherapy in head and neck cancers. J Health Rehabil Res. 2024, 4:1. 10.61919\/jhrr.v4i1.624","journal-title":"J Health Rehabil Res"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-020-00093-2","article-title":"Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw","volume":"12","author":"He L","year":"2020","unstructured":"He L, Sun X, Liu Z, Qiu Y, Niu Y. Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. Int J Oral Sci. 2020, 12:30. 10.1038\/s41368-020-00093-2","journal-title":"Int J Oral Sci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v12i12.6194","article-title":"Medication-related osteonecrosis of the jaw in women with breast cancer: a multidisciplinary approach","volume":"12","author":"\u010cebatari\u016bnien\u0117 A","year":"2024","unstructured":"\u010cebatari\u016bnien\u0117 A. Medication-related osteonecrosis of the jaw in women with breast cancer: a multidisciplinary approach. Med Res Archives. 2024, 12:1-10. 10.18103\/mra.v12i12.6194","journal-title":"Med Res Archives"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero SL","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg. 2022, 80:920-43. 10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/393520-potential-role-of-oral-microbiota-in-medication-related-osteonecrosis-of-the-jaw-in-cancer-patients-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T04:24:58Z","timestamp":1755059098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/393520-potential-role-of-oral-microbiota-in-medication-related-osteonecrosis-of-the-jaw-in-cancer-patients-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.89943","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}